SHELTON, CT, December 9, 2025 (EZ Newswire) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) today reported that ...
MyPEAK-1 Protocol Amendments Agreed Upon with FDA; Tenaya Implementing Changes with SitesSOUTH SAN FRANCISCO, Calif., Dec. 11 ...
News Medical on MSN
Cleveland Clinic presents final results of phase 1 clinical trial of preventive breast cancer vaccine study
Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple ...
Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple ...
2don MSN
Cleveland Clinic researchers share promising results from experimental breast cancer vaccine trial
After decades of research, Phase 1 of a Cleveland Clinic study shows a breast cancer vaccine is safe and triggers an immune ...
FT819 continues to demonstrate meaningful decrease in disease and favorable safety profile with twelve systemic lupus erythematosus (SLE) patients now treated; first systemic sclerosis (SSc) patient t ...
Overall response rate (ORR) of 55% and median progression-free survival of 14.5 months in patients without TP53 gene mutation ...
Southern Illinois Healthcare is expanding its cancer clinical trials program, offering patients access to advanced therapies ...
Philadelphia, PA, USA, December 9, 2025, First Patient Enrolled in GOG-3133/ FRAmework-01 Phase 3 Study Evaluating Sofetabart ...
Southern Illinois Healthcare (SIH) is opening the door to some of the most advanced cancer treatments in the world, ...
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the dosing of the first participant in a global Phase 1/1b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback